Sabby Management’s Prothena Corp PRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-240
Closed -$74K 172
2018
Q1
$74K Hold
240
0.01% 138
2017
Q4
$900K Sell
240
-759
-76% -$38.6K 0.08% 78
2017
Q3
$6.47M Buy
999
+146
+17% +$8.94K 0.42% 31
2017
Q2
$4.62M Buy
853
+193
+29% +$10.3K 0.3% 42
2017
Q1
$3.68M Buy
660
+170
+35% +$8.93K 0.2% 57
2016
Q4
$2.41M Buy
490
+165
+51% +$9.1K 0.14% 90
2016
Q3
$1.95M Buy
+325
New +$17.4K 0.07% 133
2014
Q2
Sell
-225
Closed -$862K 284
2014
Q1
$862K Buy
+225
New +$7.25K 0.05% 144

Other funds holding PRTA

Sabby Management's PRTA Position: Q2 2018 in Review

Sabby Management sold out of Prothena Corp (PRTA) in Q2 2018, closing a stake of 24,500 shares — an estimated $899K sold.

Sabby Management first reported a position in PRTA in Q4 2013 and held it in 5 quarters. The position peaked at $1.65M in Q1 2016. 125 funds tracked by Wall St. Rank hold PRTA as of Q2 2018.

  • Sabby Management reported no remaining Prothena Corp position as of Q2 2018 after selling out during the quarter.
  • Sabby Management sold 24,500 Prothena Corp shares in Q2 2018, an estimated $899K.
  • Sabby Management first reported a position in Prothena Corp in Q4 2013 and held it in 5 quarters.
  • Sabby Management's Prothena Corp position peaked at $1.65M in Q1 2016.
  • 125 funds tracked by Wall St. Rank held Prothena Corp as of Q2 2018.

Based on Sabby Management's 13F filing for Q2 2018, filed 14 Aug 2018.